Shionogi & Co., Ltd. has concluded a 300 billion yen bridge loan agreement on March 27, 2026, related to an additional investment in ViiV Healthcare Ltd., with borrowing execution planned for March 31.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4507","jir_company_name":"Shionogi & Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-03-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/4507-20260327-01.pdf","jir_short_summary":"Shionogi & Co., Ltd. has concluded a 300 billion yen bridge loan agreement on March 27, 2026, related to an additional investment in ViiV Healthcare Ltd., with borrowing execution planned for March 31.","jir_summary":"### Overview of Loan Agreement\nShionogi & Co., Ltd. concluded a 300 billion yen bridge loan agreement with Sumitomo Mitsui Banking Corporation on March 27, 2026, relating to the additional investment in ViiV Healthcare Ltd. announced on January 20, 2026. The loan execution date is March 31, 2026, with an interest rate composed of the base rate plus a spread, unsecured. The final repayment date is March 26, 2027.\n\n### Outlook and Impact on Performance\nThe procured funds are planned to be refinanced into medium- to long-term funds by the repayment deadline. The impact on consolidated earnings forecast for the fiscal year ending March 2026 is considered minor, while the impact on the fiscal year ending March 2027 is currently under review and will be promptly disclosed as necessary. Additionally, including a bridge loan related to the acquisition from Tanabe Pharma around the same period, total fund procurement amounts to 660 billion yen.","jir_financial_highlights":"Loan Amount: 300 billion yen (Unknown)\nLender: Sumitomo Mitsui Banking Corporation (Unknown)\nFinal Repayment Date: 2027-03-26 (Unknown)","jir_category":"","jir_hashtags":"#ShionogiCoLtd, #GeneralIR, #JapaneseStocks","jir_key_figures":"Loan Amount: 300 billion yen (bridge loan related to additional investment in ViiV Healthcare Ltd.)\nLender: Sumitomo Mitsui Banking Corporation\nFinal Repayment Date: 2027-03-26","jir_meta_title":"Shionogi & Co., Ltd. Concludes 300 Billion Yen Bridge Loan Agreement Related to Additional Investment in ViiV Healthcare Ltd.","jir_meta_description":"On March 27, 2026, Shionogi & Co., Ltd. announced the conclusion of a 300 billion yen bridge loan agreement connected to its additional investment in ViiV Healthcare Ltd. The impact on fiscal 2026 earnings is expected to be minimal.","jir_og_title":"Shionogi & Co., Ltd. Concludes 300 Billion Yen Bridge Loan Agreement","jir_og_description":"Shionogi & Co., Ltd. has entered into a 300 billion yen loan agreement related to the additional investment in ViiV Healthcare Ltd. The impact on financial performance is minor.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6919,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-37347","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n